Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 03, 2015 16:01 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies to Participate in Upcoming Investor and Scientific Conferences

NEW YORK, Sept. 3, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TIL),...
August 31, 2015 08:00 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies Announces Strategic Hires

NEW YORK, Aug. 31, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes...
August 10, 2015 16:00 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies Announces Second Quarter 2015 Financial Results

NEW YORK, Aug. 10, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes...
June 24, 2015 08:00 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies to Join Russell Global Index

LOS ANGELES, June 24, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes...
June 10, 2015 12:00 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies Receives Orphan Drug Designation for LN-144 for the Treatment of Malignant Melanoma

LOS ANGELES, June 10, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes...
June 08, 2015 08:00 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies Names Molly Henderson Chief Financial Officer

LOS ANGELES, June 8, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes...
May 19, 2015 08:00 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies to Participate in Upcoming Investor Conferences

LOS ANGELES, May 19, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO) today announced that president and CEO Elma Hawkins, PhD, will participate in the following upcoming investor...
May 01, 2015 08:45 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies Announces Pricing of Secondary Offering of Shares by Selling Stockholders

LOS ANGELES, May 1, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes,...
April 08, 2015 08:26 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies Announces Publication of Data From Clinical Study of Metastatic Cervical Cancer Patients Treated With HPV-TIL

LOS ANGELES, April 8, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes...
March 30, 2015 06:00 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies Announces Positive Data From a TIL-Ipilimumab Combination Study in Melanoma

LOS ANGELES, March 30, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating...